来自纽约干细胞基金会(NYSCF)研究所和凯斯西储大学的一组科学家创建了迄今为止最大的多发性硬化症(MS)患者干细胞模型集合,并利用它们来识别胶质细胞(大脑中完整的支持细胞)导致这种疾病的独特方式。 来自纽约干细胞基金会(NYSCF)研究所和凯斯西储大学的一组科学家创建了最大的多发性硬化症(MS)患者干细胞模型集合,...
来自纽约干细胞基金会(NYSCF)研究所和凯斯西储大学的一组科学家创建了迄今为止最大的多发性硬化症(MS)患者干细胞模型集合,并利用它们来识别胶质细胞(大脑中完整的支持细胞)导致这种疾病的独特方式。 今天发表在《Cell Stem Cell》杂志上的这项研究...
Americans who want to treat their MS with a stem cell transplant have a tough road to follow. They’re forced to travel to Russia, Mexico, or somewhere else out of the country and to spend a lot of money to avoid the U.S. Food and Drug Administration’s stem cell treatment barrier....
Stem Cell Therapy for MS Shows Promise More By Dennis ThompsonHealthDay Reporter HealthDay MONDAY, Dec. 29, 2014 (HealthDay News) -- An experimental therapy that kills off and then "resets" the immune system has given three years of remission to a small group of multiple sclerosis patients,...
ESI鈥揗S/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts ESI-MS/MS and MALDI-IMS localization reveal alterations in phosphatidic acid, diacylglycerol, and DHA in glioma stem cell xenografts. J Proteome Res (... ...
The identification of multipotential mesenchymal stem cells (MSCs) derived from adult human tissues, including bone marrow stroma and a number of connective tissues, has provided exciting prospects for cell-based tissue engineering and regeneration. This
MSC-Exos to be used in clinical trials must be produced under the GMP-grade condition in which the cell culture environment, cultivation system, dissipation enzyme, and culture medium are strictly monitored using GMP standards. MSC-Exos need to be purified and characterized for physical structure ...
"Primary progressive MS is a devastating disease for which we are still missing effective treatments, and regenerating myelin is a major need that current therapeutics have not met," said Valentina Fossati of the New York Stem Cell Foundation. ...
Autologous haematopoietic stem cell transplantation (AHSCT) is a treatment option for some forms of multiple sclerosis (MS), but uncertainties remain about its implementation in clinical practice and treatment protocols need to be optimized. This Consensus Statement provides guidance and recommendations for...
(HealthDay)—A stem cell transplant may help some people with multiple sclerosis (MS) when standard drugs fail, a new clinical trial finds.